Larimar Therapeutics (LRMR) Free Cash Flow (2013 - 2025)
Larimar Therapeutics (LRMR) posted Free Cash Flow of $19000.0 for Q4 2025, down 84.43% on a QoQ basis from $122000.0 in Q3 2025, and up 100.09% year-over-year from $9495.9 in Q4 2024.
Larimar Therapeutics (LRMR) Free Cash Flow (2013 - 2025) Analysis & Trends
Larimar Therapeutics' Free Cash Flow history runs 13 years deep, the most recent figure standing at $19000.0 for Q4 2025.
- Quarterly Free Cash Flow rose 100.09% year-over-year to $19000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$45.8 million (up 35.67% YoY) and the FY2025 annual result came in at -$113.1 million, down 58.72% from the prior year.
- Free Cash Flow was $19000.0 for Q4 2025 at Larimar Therapeutics, down from $122000.0 in the prior quarter.
- Across five years, Free Cash Flow topped out at $122000.0 in Q3 2025 and bottomed at -$26.5 million in Q1 2025.
- A 5-year average of -$11.0 million and a median of -$9.4 million in 2023 frame the typical range for Free Cash Flow.
- Annual changes were most pronounced in 2024 — Free Cash Flow sank 171.0% — and 2025, when it surged 100.49%.
- Larimar Therapeutics' Free Cash Flow stood at -$8.2 million in 2021, then increased by 19.11% to -$6.7 million in 2022, then plunged by 43.27% to -$9.6 million in 2023, then plunged by 130.26% to -$22.0 million in 2024, then jumped by 100.09% to $19000.0 in 2025.
- Business Quant data shows LRMR's Free Cash Flow at $19000.0 in Q4 2025, $122000.0 in Q3 2025, and -$19.5 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | -19.58 Mn |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | -2.49 Mn |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 158.09 Mn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 1.29 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | 848.30 Mn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | -354.95 Mn |
| 10 | Larimar Therapeutics | 37.00 Mn | -99.85 Mn | - | 19,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 19,000.00 |
| Dec 31, 2025 | 19,000.00 |
| Sep 30, 2025 | 122,000.00 |
| Sep 30, 2025 | 122,000.00 |
| Jun 30, 2025 | -19.46 Mn |
| Jun 30, 2025 | -19.46 Mn |
| Mar 31, 2025 | -26.53 Mn |
| Mar 31, 2025 | -26.53 Mn |
| Dec 31, 2024 | -21.99 Mn |
| Dec 31, 2024 | -21.99 Mn |
| Sep 30, 2024 | -24.91 Mn |
| Sep 30, 2024 | -24.91 Mn |
| Jun 30, 2024 | -13.95 Mn |
| Jun 30, 2024 | -13.95 Mn |
| Mar 31, 2024 | -10.43 Mn |
| Mar 31, 2024 | -10.43 Mn |
| Dec 31, 2023 | -9.55 Mn |
| Dec 31, 2023 | -9.55 Mn |
| Sep 30, 2023 | -9.19 Mn |
| Sep 30, 2023 | -9.19 Mn |